Search Results - "Selkoe, Dennis J."

Refine Results
  1. 1

    Treatments for Alzheimer's disease emerge by Selkoe, Dennis J.

    “…Anti-amyloid immunotherapies will provide the first disease-modifying therapeutics Few of life's experiences evoke greater apprehension than a diagnosis of…”
    Get full text
    Journal Article
  2. 2

    The amyloid hypothesis of Alzheimer's disease at 25 years by Selkoe, Dennis J, Hardy, John

    Published in EMBO molecular medicine (01-06-2016)
    “…Despite continuing debate about the amyloid β‐protein (or Aβ hypothesis, new lines of evidence from laboratories and clinics worldwide support the concept that…”
    Get full text
    Journal Article
  3. 3

    Preventing Alzheimer's Disease by Selkoe, Dennis J.

    “…Despite intensive laboratory and clinical research over three decades, an effective treatment to delay the onset and progression of Alzheimer's disease is not…”
    Get full text
    Journal Article
  4. 4

    Early network dysfunction in Alzheimer's disease by Selkoe, Dennis J

    “…Small aggregates of β-amyloid peptide can hyperactivate neurons, which compromises neural networks Aggregation of the β-amyloid peptide (Aβ) in brain regions…”
    Get full text
    Journal Article
  5. 5

    A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration by Walsh, Dominic M., Selkoe, Dennis J.

    Published in Nature reviews. Neuroscience (01-04-2016)
    “…There has been a surge in the number of papers discussing the idea that inter-neuronal spread of 'pathogenic' proteins contributes to neurodegenerative disease…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The therapeutics of Alzheimer's disease: Where we stand and where we are heading by Selkoe, Dennis J.

    Published in Annals of neurology (01-09-2013)
    “…Few diagnoses in modern medicine evoke more apprehension in patients and their families than Alzheimer disease (AD). Defined as a clinical and pathological…”
    Get full text
    Journal Article
  8. 8

    Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration by Jin, Ming, Shepardson, Nina, Yang, Ting, Chen, Gang, Walsh, Dominic, Selkoe, Dennis J., Petsko, Gregory A.

    “…Alzheimer disease is a major cause of cognitive failure, and a pathogenically related but more subtle process accounts for many cases of mild memory symptoms…”
    Get full text
    Journal Article
  9. 9

    Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases by Selkoe, Dennis J

    Published in Nature cell biology (01-11-2004)
    “…The salutary intersection of fundamental cell biology with the study of disease is well illustrated by the emerging elucidation of neurodegenerative disorders…”
    Get full text
    Journal Article
  10. 10

    Alzheimer's Disease Is a Synaptic Failure by Selkoe, Dennis J.

    “…In its earliest clinical phase, Alzheimer's disease characteristically produces a remarkably pure impairment of memory. Mounting evidence suggests that this…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers by Li, Shaomin, Jin, Ming, Zhang, Dainan, Yang, Ting, Koeglsperger, Thomas, Fu, Hongjun, Selkoe, Dennis J.

    Published in Neuron (Cambridge, Mass.) (06-03-2013)
    “…A central question about human brain aging is whether cognitive enrichment slows the development of Alzheimer changes. Here, we show that prolonged exposure to…”
    Get full text
    Journal Article
  13. 13

    Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes by Hong, Soyon, Ostaszewski, Beth L., Yang, Ting, O’Malley, Tiernan T., Jin, Ming, Yanagisawa, Katsuhiko, Li, Shaomin, Bartels, Tim, Selkoe, Dennis J.

    Published in Neuron (Cambridge, Mass.) (16-04-2014)
    “…Soluble Aβ oligomers contribute importantly to synaptotoxicity in Alzheimer’s disease, but their dynamics in vivo remain unclear. Here, we found that soluble…”
    Get full text
    Journal Article
  14. 14

    Nicastrin functions to sterically hinder γ-secretase–substrate interactions driven by substrate transmembrane domain by Bolduc, David M., Montagna, Daniel R., Gu, Yongli, Selkoe, Dennis J., Wolfe, Michael S.

    “…γ-Secretase is an intramembrane-cleaving protease that processes many type-I integral membrane proteins within the lipid bilayer, an event preceded by shedding…”
    Get full text
    Journal Article
  15. 15

    The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking by Meissner, Cathrin, Lorenz, Holger, Weihofen, Andreas, Selkoe, Dennis J., Lemberg, Marius K.

    Published in Journal of neurochemistry (01-06-2011)
    “…J. Neurochem. (2011) 117, 856–867. Intramembrane proteolysis is a conserved mechanism that regulates a variety of cellular processes ranging from transcription…”
    Get full text
    Journal Article
  16. 16

    miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer's Patients by Cha, Diana J, Mengel, David, Mustapic, Maja, Liu, Wen, Selkoe, Dennis J, Kapogiannis, Dimitrios, Galasko, Douglas, Rissman, Robert A, Bennett, David A, Walsh, Dominic M

    Published in Frontiers in neuroscience (26-11-2019)
    “…It was recently discovered that brain cells release extracellular vesicles (EV) which can pass from brain into blood. These findings raise the possibility that…”
    Get full text
    Journal Article
  17. 17

    The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons by Muratore, Christina R, Rice, Heather C, Srikanth, Priya, Callahan, Dana G, Shin, Taehwan, Benjamin, Lawrence N P, Walsh, Dominic M, Selkoe, Dennis J, Young-Pearse, Tracy L

    Published in Human molecular genetics (01-07-2014)
    “…Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by extracellular plaques containing amyloid β (Aβ)-protein and intracellular…”
    Get full text
    Journal Article
  18. 18

    The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics by Hardy, John, Selkoe, Dennis J.

    “…It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid…”
    Get full text
    Journal Article
  19. 19

    Alzheimer's Disease: Genes, Proteins, and Therapy by Selkoe, Dennis J

    Published in Physiological reviews (01-04-2001)
    “…Department of Neurology and Program in Neuroscience, Harvard Medical School, and Center for Neurologic Diseases, Brigham and Women's Hospital, Boston,…”
    Get full text
    Journal Article
  20. 20

    N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation by Bartels, Tim, Kim, Nora C, Luth, Eric S, Selkoe, Dennis J

    Published in PloS one (30-07-2014)
    “…A switch in the conformational properties of α-synuclein (αS) is hypothesized to be a key step in the pathogenic mechanism of Parkinson's disease (PD). Whereas…”
    Get full text
    Journal Article